Temasek Holdings, a Singapore-based investment company, has become a shareholder in HealthCare Global Enterprises (HCG).
Temasek joins existing investors, Premji Invest and Milestone Religare in a primary equity issuance by the company. Evolvence India Life Sciences Fund, which has been an investor in HCG since 2007, will be exiting their investment to Temasek in the Company.
“We are happy to bring on board an equity partner of the stature of Temasek as we begin the next phase of growth. Temasek’s global perspective and long term interest in healthcare makes them a valuable partner. We also welcome Dr Jennifer Lee to our board and look forward to benefitting from her vast experiences in health management and policy,” said Dr BS Ajaikumar, Chairman and CEO of HCG Enterprises.
“We are pleased to have the opportunity to invest in HCG, who have redefined cancer care in India,” said Rohit Sipahimalani, Head- India, Temasek Holdings.
EH News Bureau
- Advertisement -
